Elucid is a diagnostic imaging company that uses artificial intelligence to improve vascular patient outcomes. With a mission to prevent cardiovascular disease and improve pathology accuracy, Elucid optimizes clinical precision with arterial plaque analysis. Elucid also features ct angiography, FFRct, plaque characterization, and non-coding transcripts. Elucid was founded by Andrew J. Buckler in 2013 and is headquartered in Boston, MA.

Register for Details

For more details on financing and valuation for Elucid, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Elucid

Forge green plus iconForge green minus icon

What is Elucid's IPO price?

The IPO price for Elucid will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Elucid?

Elucid is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Elucid share pre-IPO?

If you own Elucid pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Elucid a publicly traded company?

Elucid is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Elucid founded?

Elucid was founded in 2009.

Who are Elucid's major investors?

National Institutes of Health
IAG Capital Partners
Global Health Investment Fund
Elevage Medical Technologies
Aphelion Capital
Biovision Ventures
Philips Ventures
BlueStone Venture Partners
Bold Brain Ventures
Ice Age Gold
MedTex Ventures
Willamette Valley Capital
University of Michigan Endowment
Updated on: Nov 17, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.